+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Prostaglandin D2 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Prostaglandin D2 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic M1 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic M1 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Selectin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Selectin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vascular Endothelial Growth Factor A Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Endothelial Growth Factor A Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025 - Product Thumbnail Image

Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
5-HT2C Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2C Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Bradykinin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Bradykinin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatorenal Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatorenal Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Menorrhagia - Pipeline Insight, 2025 - Product Thumbnail Image

Menorrhagia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Cardiovascular Calcification - Pipeline Insight, 2025 - Product Thumbnail Image

Cardiovascular Calcification - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Lymphoedema- Pipeline Insight, 2025 - Product Thumbnail Image

Lymphoedema- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Cocaine Use Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Congenital Adrenal Hyperplasia- Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Adrenal Hyperplasia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Systemic Inflammatory Response Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Inflammatory Response Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Adult-Onset Still Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Adult-Onset Still Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Homocystinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Homocystinuria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more